Plasma ghrelin, leptin, and orexin-A levels and insulin resistance after laparoscopic gastric band applications in morbidly obese patients

Minerva Medica

Volumn 104, Issue 3, 2013, Pages 309-316

  Cigdem Arica, P ^a   Kocael, A ^a   Tabak, O ^b   Taskin, M ^a   Zengin, K ^a   Uzun, H ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

^b Kanuni Sultan Suleyman Education and Research Hospital   (Turkey)

Author keywords

Insulin resistance; Leptin; Obesity

Indexed keywords

GHRELIN; LEPTIN; OREXIN A;

ADULT; ARTICLE; BLOOD SAMPLING; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GASTRIC BANDING; HUMAN; INSULIN RESISTANCE; LAPAROSCOPIC SURGERY; MALE; OBESITY; WEIGHT REDUCTION;

ADULT; BODY MASS INDEX; CASE-CONTROL STUDIES; ENERGY METABOLISM; FEMALE; GASTROPLASTY; GHRELIN; HUMANS; INSULIN RESISTANCE; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LAPAROSCOPY; LEPTIN; MALE; NEUROPEPTIDES; OBESITY, MORBID; WEIGHT LOSS;

EID: 84882345239     PISSN: 00264806     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Allison DB, Fontaine KR, Manson JE, Stevens J, Vanltallie TB. Annual deaths attributable to obesity in the United States. JAMA 1999;282:1530-8.
2. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality-from cancer in a prospectively studied cohort of U. S adults. N-Engl J Med 2003;348:1625-38.
3. Flegal KM, Carroll MD, Ogden CL, Johnsoa CL. Pre-valeoce and trends in obesity among US adults 1999-2000. JAMA 2002;288:1723
4. Fontaine KR, Redden DT, Wartg C, Westfall AO, Allison DB. Years of life lost due to obesity. JAMA 2003;289:187-93.
5. Ford ES, Mokdad AH, Giles WH. Trends in waist circumference among U. S. adults. Obes Res 2003;11:1223-31.
6. Foster-Schubert KE, Cummings DE. Emerging therapeutic strategies for obesity. Endocr Rev 2006;27:779-93.
7. Bray GA, Tartaglia LA. Medicinal strategies in the 'treatment of obesity. Nature 2000;404:672-7.
8. Anderson JW, Konz EC, Frederich RC, Wood CL. Long-term weight-loss maintenance: a meta-analysis of US studies. Am J Clin Nutr 2001;74:579-84.
9. Deitel M, Shikora SA. The development of the surgical treatment of morbid obesity. J Am Coll Nutr 2002;21:365-71.
10. Colquitt J, Clegg A, Sidhu M et al. Surgery for morbid obesity. The Cochrane Database Systematic Reviews 2003;2:CD00364l. DOI: 10.1002/14651858. CD003641
11. Flier JS. What's in a name? In search of leptin's physiologic role. Journal of Clinical Endocrinology and Metabolism 1998;83:1407-1413.
12. Criscione L, Rigollier P, Batzl-Hartmann C, Riieger H, Stricker-Krongrad A, Wyss P et al. Food intake in free-feeding and energydeprived lean rats is mediated by the neuropeptide Y5 receptor. J Clin Invest 1998;102:2136-45.
13. Sakurai T, Amemiya A, Ishii M, Matsuzaki I, Chemelli RM, Tanaka H et al. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G proteincoupled receptors that regulate feeding behavior. Cell 1998;92:573-85.
14. Ganjavi H, Shapiro CM. Hypocretin/Orexin: a molecular link between sleep, energy regulation, and pleasure. J Neuropsychiatry Clin Neurosci 2007;19:413-9.
15. Kawada Y, Hayashibe H, Asayama K et al. Plasma Levels of Orexin-A and Leptin in Obese Children. Clin Pediatr Endocrinol 2004;13:47-53.
16. Cummings DE, Foster-Schubert KE, Overduin J. Ghrelin and energy balance: focus on current controversies. Curr Drug Targets 2005;6:153-69.
17. Cummings DE, Purnell JQ, Frayo RS, Schmidova K, Wisse BE, Weigle DS. A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans. Diabetes 2001;50:1714-9.
18. Drazen DL, Vahl TP, D'Alessio DA, Seeley RJ, Woods SC. Effects of a fixed meal pattern on ghrelin secretion: evidence for a learned response independent of nutrient status. Endocrinology 2006;147:23-30.
19. Muniyappa R, Lee S, Chen H, Quon MJ. Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations, and appropriate usage. Am J Physiol Endocrinol Metab 2008;294:E15-26.
20. [No authors listed]. Gastrointestinal surgery for severe obesity: National Institutes of Health Consensus Development Conference Statement. Am J Clin Nutr 1992;55:S615-9.
21. Klok MD, Jakobsdottir S, Drent ML. The role of leptin and ghrelin in the regulation of food intake and body weight in humans: a review. Obes Rev 2007;8:21-34.
22. De Fronzo RA, Ferraninni E. Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia and atherosclerotic disease. Diabetes Care 1991;14:173-94.
23. Williams IL, Chowienczyk PJ, Wheatcroft SB, Patel AG, Sherwood RA, Momin A et al. Endothelial function and weight loss in obese humans. Obes Surg 2005;15:1055-60.
24. Ritt M, Piza H, Rhomberg M, Aigner F, Lechleitner M. Metabolic risk factors in formerly obese womeneffects of a pronounced weight loss by gastric band operation compared with weight loss by diet alone. Diabetes Obes Metab 2005;7:216-22.
25. Knerr I, Herzog D, Rauh M, Rascher W, Horbach T. Leptin and ghrelin expression in adipose tissues and serum levels in gastric banding patients. Eur J Clin Invest 2006;36:389-94.
26. Friihbeck G, Diez-Caballero A, Gomez-Ambrosi J, Gil MJ, Monreal I, Salvador J et al. Disruption of the leptin-insulin relationship in obese men 24 hours after laparoscopic adjustable silicone gastric banding. Obes Surg 2002;12:366-71.
27. Foster-Schubert KE, Cummings DE. Emerging therapeutic strategies for obesity. Endocr Rev 2006;27:779-93.
28. Weigle DS, Cummings DE, Newby PD, Breen PA, Frayo RS, Matthys CC et al. Roles of leptin and ghrelin in the loss of body weight caused by a low fat, high carbohydrate diet. J Clin Endocrinol Metab 2003;88:1577-86.
29. Cummings DE, Foster-Schubert KE, Overduin J. Ghrelin and energy balance: focus on current controversies. Curr Drug Targets 2005;6:153-69.
30. Cummings DE, Purnell JQ, Frayo RS, Schmidova K, Wisse BE, Weigle DS. A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans. Diabetes 2001;50:1714-9.
31. Faraj M, Havel PJ, Phelis S, Blank D, Sniderman AD, Cianflone K. Plasma acylation-stimulating protein, adiponectin, leptin, and ghrelin before and after weight loss induced by gastric bypass surgery in morbidly obese subjects. J Clin Endocrinol Metab 2003;88:1594-602.
32. Cummings DE, Weigle DS, Frayo RS, Breen PA, Ma MK, Dellinger EP et al. Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. N Engl J Med 2002;346:1623-30.
33. Geloneze B, Tambascia MA, Pilla VF, Geloneze SR, Repetto EM, Pareja JC. Ghrelin: a gut-brain hormone: effect of gastric bypass surgery. Obes Surg 2003;13:17-22.
34. Tritos NA, Mun E, Bertkau A et al. Serum ghrelin levels in response to glucose load in obese subjects post-gastric bypass surgery. Obes Res. 2003;11:919-24.
35. Tschop M, Weyer C, Tataranni PA, Devanarayan V, Ravussin E, Heiman ML. Circulating ghrelin levels are decreased in human obesity. Diabetes 2001;50:707-9.
36. Hagan JJ, Leslie RA, Patel S, Evans ML, Wattam TA, Holmes S et al. Orexin A activates locus coeruleus cell firing and increases arousal in the rat. Proc Natl Acad Sci USA 1999;96:10911-6.
37. Nowak KW, Mackowiak P, Switonska MM, Fabi S M, Malendowicz LK. Acute orexin effects on insulin secretion in the rat: in vivo and in vitro studies. Life-Sci 2000;66:449-54.
38. Korczynski W, Ceregrzyn M, Matyjek R, Kato I, Kuwahara A, Wolinski J. Central and local (enteric) action of orexins. J Physiol Pharmacol 2006;57(Suppl 6):17-42.
39. Adam JA, Meuheere P P C A, Van Dielen F M H, Soeters PB, Buurman WA, Greve JW. Decreased plasma orexin - A levels in obese individuals. Intern J Ob 2002;26:274-6.
40. Baranowska B, Wolinska-Witort E, Martyriska L, Chmielowska M, Baranowska-Bik A. Plasma orexin A, orexin B, leptin, neuropeptide Y (NPY) and insulin in obese women. Neuro Endocrinol Lett 2005;26:293-6.
41. Heinonen MV, Purhonen AK, Miettinen P, Paakkonen M, Pirinen E, Alhava E et al. Apelin, orexin-A and leptin plasma levels in morbid obesity and effect of gastric banding. Regul Pept 2005;130:7-13.